The year 2025 marked a significant shift in the integration of artificial intelligence into healthcare, as the technology moved from experimental phases into active use across clinical and commercial settings. AI, once viewed as a long-term prospect, began delivering practical benefits, with healthcare organisations adopting it to streamline operations, enhance patient communication and improve medical outcomes.
Throughout the year, generative AI was deployed more widely in hospitals, clinics and pharmaceutical companies. Clinical teams used it to produce care plans and patient notes in real time, reducing time spent on documentation and allowing more focus on decision-making and patient care. Predictive AI was applied to flag potential hospital readmissions and other risks before they materialised, contributing to efficiency gains and better patient outcomes. At the same time, AI-generated, multi-language patient education materials helped address gaps in communication, particularly for underserved populations.
In the pharmaceutical and healthcare marketing sectors, data intelligence and targeting technologies helped refine how companies engaged with both clinicians and patients. Rather than relying on broad messaging, marketers used AI-driven insights to tailor communications more precisely, increasing engagement and improving return on investment.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.
